Showing results (171-180 of 246) with videos related to
Sort By:
Pageof 25
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and BiomarkersHimisha Beltran, Clara Oromendia, Daniel C Danila, et al.Molecular Cancer Therapeutics|January 19, 2012
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor targetColin C Collins, Stanislav V Volik, Anna V Lapuk, et al.Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.Biorxiv : the Preprint Server for Biology|September 15, 2025
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader moleculesPhillip Thienger, Irene Paassen, Xiaosai Yao, et al.Advanced Materials (Deerfield Beach, Fla.)|October 22, 2021
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 InhibitorsMatthew J Mosquera, Sungwoong Kim, Rohan Bareja, et al.Nature Communications|July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signalingBrian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.Nature Communications|November 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancerShankha S Chatterjee, Juan F Linares, Tania Cid-Diaz, et al.Cell Reports|August 4, 2015
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.Cancer Research|March 5, 2026
Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine ProgressionArianna Brevi, Marco Lorenzoni, Sara Caputo, et al.Pageof 25